Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Kymera

Kymera
2016 FOUNDED
PRIVATE STATUS
11-20 EMPLOYEES
Series B LATEST DEAL TYPE
$65M LATEST DEAL AMOUNT
10 INVESTORS
Description

Operator of a biotech firm intended to research intended to treat previously untreatable diseases. The company's platform engages in targeted protein degradation to access the body's innate protein recycling machinery, enabling patients to receive treatment for incurable diseases.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Pharmaceuticals
Primary Office
  • 300 Technology Square
  • 2nd Floor
  • Cambridge, MA 02139
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Kymera’s full profile, request a free trial.

Kymera Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC (Series B) 13-Nov-2018 $65M 0000 Completed Generating Revenue
3. Early Stage VC (Series A) 30-Oct-2017 0000 0000 Completed Generating Revenue
2. Accelerator/Incubator Completed Generating Revenue
1. Accelerator/Incubator Completed Generating Revenue
To view this company’s complete deal history including valuation and funding, request access »

Kymera Investors (10)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
6 Dimensions Capital Venture Capital Minority 000 0000 000000 0
AJU IB Investment Venture Capital Minority 000 0000 000000 0
Bessemer Venture Partners Venture Capital Minority 000 0000 000000 0
Hatteras Venture Partners Venture Capital Minority 000 0000 000000 0
MRL Ventures Fund Corporate Venture Capital Minority 000 0000 000000 0
You’re viewing 5 of 10 investors. Get the full list »

Kymera Executive Team (5)

Name Title Board
Seat
Contact
Info
Laurent Audoly Ph.D Chief Executive Officer, President & Board Member
Nello Mainolfi Ph.D Co-Founder & Chief Technology Officer
Mark Nuttall Ph.D Chief Business Officer
Bruce Booth Ph.D Co-Founder & Chairman
Jared Gollob MD Chief Medical Officer

Kymera Board Members (8)

Name Representing Role Since Contact
Info
Andrew Hedin Bessemer Venture Partners Board Member 000 0000
Bruce Booth Ph.D Kymera Co-Founder & Chairman 000 0000
Donald Nicholson Ph.D Self Board Member 000 0000
Elaine Jones Ph.D Pfizer Ventures Board Member 000 0000
Joanna Horobin Self Board Member 000 0000
You’re viewing 5 of 8 board members. Get the full list »